Sylvie Callegari

821 total citations
20 papers, 490 citations indexed

About

Sylvie Callegari is a scholar working on Molecular Biology, Epidemiology and Cell Biology. According to data from OpenAlex, Sylvie Callegari has authored 20 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Cell Biology. Recurrent topics in Sylvie Callegari's work include Mitochondrial Function and Pathology (12 papers), ATP Synthase and ATPases Research (7 papers) and Autophagy in Disease and Therapy (4 papers). Sylvie Callegari is often cited by papers focused on Mitochondrial Function and Pathology (12 papers), ATP Synthase and ATPases Research (7 papers) and Autophagy in Disease and Therapy (4 papers). Sylvie Callegari collaborates with scholars based in Germany, Australia and United Kingdom. Sylvie Callegari's co-authors include Peter Rehling, Sven Dennerlein, Luis Daniel Cruz‐Zaragoza, David Komander, Zhong Yan Gan, Andrew Leis, Grant Dewson, Simon A. Cobbold, Alisa Glukhova and Jan Dudek and has published in prestigious journals such as Nature, Science and Journal of Molecular Biology.

In The Last Decade

Sylvie Callegari

17 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Callegari Germany 12 384 111 98 61 44 20 490
Raghav Kalia United States 6 505 1.3× 76 0.7× 142 1.4× 81 1.3× 13 0.3× 6 573
Mari J. Aaltonen Canada 9 620 1.6× 120 1.1× 168 1.7× 132 2.2× 40 0.9× 10 712
Takayuki Kanazawa Japan 9 565 1.5× 98 0.9× 157 1.6× 87 1.4× 20 0.5× 17 685
Richard G. Lee Australia 10 398 1.0× 41 0.4× 46 0.5× 42 0.7× 25 0.6× 12 549
Chantal Priesnitz Germany 7 451 1.2× 68 0.6× 76 0.8× 118 1.9× 13 0.3× 8 501
Lauren F. Uchiyama United States 2 450 1.2× 81 0.7× 133 1.4× 106 1.7× 20 0.5× 6 512
Petrina Delivani Ireland 8 503 1.3× 80 0.7× 44 0.4× 100 1.6× 21 0.5× 9 583
Yu-Lu Cao China 3 315 0.8× 72 0.6× 92 0.9× 35 0.6× 9 0.2× 4 380
Tadato Ban Japan 5 513 1.3× 73 0.7× 197 2.0× 44 0.7× 11 0.3× 7 564
V. B. Saprunova Russia 9 384 1.0× 79 0.7× 69 0.7× 34 0.6× 10 0.2× 14 483

Countries citing papers authored by Sylvie Callegari

Since Specialization
Citations

This map shows the geographic impact of Sylvie Callegari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Callegari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Callegari more than expected).

Fields of papers citing papers by Sylvie Callegari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Callegari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Callegari. The network helps show where Sylvie Callegari may publish in the future.

Co-authorship network of co-authors of Sylvie Callegari

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Callegari. A scholar is included among the top collaborators of Sylvie Callegari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Callegari. Sylvie Callegari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fenech, Emma J., Meital Kupervaser, Inês Gomes Castro, et al.. (2025). Profiling the LAM Family of Contact Site Tethers Provides Insights into Their Regulation and Function. PubMed. 8. 3110331818–3110331818.
2.
Kueh, Andrew J., Martin Pál, Lin Tai, et al.. (2025). Transcriptomic changes including p53 dysregulation prime DNMT3A mutant cells for transformation. EMBO Reports. 26(11). 2855–2882.
3.
Callegari, Sylvie, Zhong Yan Gan, Toby A. Dite, et al.. (2025). Structure of human PINK1 at a mitochondrial TOM-VDAC array. Science. 388(6744). 303–310. 14 indexed citations
4.
Callegari, Sylvie. (2025). Reacting to reductive stress at the mitochondrial import gate. Trends in Cell Biology. 35(2). 94–96.
5.
Gan, Zhong Yan, David Komander, & Sylvie Callegari. (2024). Reassessing kinetin’s effect on PINK1 and mitophagy. Autophagy. 20(11). 2596–2597. 4 indexed citations
6.
Gan, Zhong Yan, Sylvie Callegari, Thanh Ngoc Nguyen, et al.. (2024). Interaction of PINK1 with nucleotides and kinetin. Science Advances. 10(3). eadj7408–eadj7408. 7 indexed citations
7.
Gan, Zhong Yan, Sylvie Callegari, Simon A. Cobbold, et al.. (2021). Activation mechanism of PINK1. Nature. 602(7896). 328–335. 117 indexed citations
8.
Callegari, Sylvie, et al.. (2021). Rcf proteins and their differential specificity for respiratory chain complexes: A unique role for Rcf2 on oxygen sensitive supercomplexes?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(12). 119133–119133. 5 indexed citations
9.
Callegari, Sylvie, A. Linden, Piotr Neumann, et al.. (2020). Defining the architecture of the human TIM22 complex by chemical crosslinking. FEBS Letters. 595(2). 157–168. 11 indexed citations
10.
Cruz‐Zaragoza, Luis Daniel, Ida Suppanz, Bernard Guiard, et al.. (2020). Defining the Substrate Spectrum of the TIM22 Complex Identifies Pyruvate Carrier Subunits as Unconventional Cargos. Current Biology. 30(6). 1119–1127.e5. 31 indexed citations
11.
Callegari, Sylvie, Luis Daniel Cruz‐Zaragoza, & Peter Rehling. (2020). From TOM to the TIM23 complex – handing over of a precursor. Biological Chemistry. 401(6-7). 709–721. 47 indexed citations
12.
Callegari, Sylvie, Tobias Müller, Christian Schulz, et al.. (2019). A MICOS–TIM22 Association Promotes Carrier Import into Human Mitochondria. Journal of Molecular Biology. 431(15). 2835–2851. 41 indexed citations
13.
Callegari, Sylvie & Sven Dennerlein. (2018). Sensing the Stress: A Role for the UPRmt and UPRam in the Quality Control of Mitochondria. Frontiers in Cell and Developmental Biology. 6. 31–31. 42 indexed citations
14.
Pacheu‐Grau, David, Sylvie Callegari, Sonia Emperador, et al.. (2018). Mutations of the mitochondrial carrier translocase channel subunit TIM22 cause early-onset mitochondrial myopathy. Human Molecular Genetics. 27(23). 4135–4144. 27 indexed citations
15.
Lorenzi, Isotta, Silke Oeljeklaus, Abhishek Aich, et al.. (2017). The mitochondrial TMEM177 associates with COX20 during COX2 biogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(2). 323–333. 22 indexed citations
16.
Callegari, Sylvie, Silke Oeljeklaus, Bettina Warscheid, et al.. (2016). Phospho-ubiquitin-PARK2 complex as a marker for mitophagy defects. Autophagy. 13(1). 201–211. 21 indexed citations
17.
Dudek, Jan, I‐Fen Cheng, Arpita Chowdhury, et al.. (2015). Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome. EMBO Molecular Medicine. 8(2). 139–154. 65 indexed citations
18.
Callegari, Sylvie, Philip A. Gregory, Matthew J. Sykes, et al.. (2012). Polymorphisms in the Mitochondrial Ribosome Recycling Factor EF-G2mt/MEF2 Compromise Cell Respiratory Function and Increase Atorvastatin Toxicity. PLoS Genetics. 8(6). e1002755–e1002755. 5 indexed citations
19.
Callegari, Sylvie, Ross A. McKinnon, Stuart Andrews, & Miguel de Barros Lopes. (2011). TheMEF2gene is essential for yeast longevity, with a dual role in cell respiration and maintenance of mitochondrial membrane potential. FEBS Letters. 585(8). 1140–1146. 9 indexed citations
20.
Callegari, Sylvie, et al.. (2009). Atorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation. FEMS Yeast Research. 10(2). 188–198. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026